NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE111620 Query DataSets for GSE111620
Status Public on Dec 05, 2019
Title RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary DNA Double-strand break (DSB) repair is critical for cell survival and genome integrity. Upon recognition of DSBs, repair proteins are transiently upregulated to facilitate repair through homologous recombination (HR) or non-homologous end joining (NHEJ). We present evidence that PRMT5 cooperates with pICln to function as a master epigenetic activator of DNA damage response (DDR) genes involved in HR, NHEJ, and G2 arrest (including RAD51, BRCA1, and BRCA2) to upregulate gene expression upon DNA damage. Contrary to the predominant role of PRMT5 as an epigenetic repressor, our results demonstrate that PRMT5 and pICln can activate gene expression, potentially independent of PRMT5’s obligate cofactor MEP50. Targeting PRMT5 or pICln hinders repair of DSBs in multiple cancer cell lines, and both PRMT5 and pICln expression positively correlates with DDR genes across 32 clinical cancer data sets. Thus, targeting PRMT5 or pICln may be explored in combination with radiation or chemotherapy for cancer treatment.
 
Overall design RNA-seq analysis of both non-irradiated and irradiated LNCaP cells with and without PRMT5 knockdown
Web link https://0-doi-org.brum.beds.ac.uk/10.1016/j.isci.2019.100750
 
Contributor(s) Owens JL, Wan J, Hu C
Citation(s) 31884170
NIH grant(s)
Grant ID Grant title Affiliation Name
R01 CA212403 Role and targeting of PRMT5 in prostate cancer PURDUE UNIVERSITY CHANG-DENG HU
R01 CA212403 Role and targeting of PRMT5 in prostate cancer PURDUE UNIVERSITY Jiaoti Huang
R01 CA212403 Role and targeting of PRMT5 in prostate cancer PURDUE UNIVERSITY Chenglong Li
P30 CA023168 Cancer Center Support Grant (CORE) Renewal PURDUE UNIVERSITY TIMOTHY L. RATLIFF
P30 CA082709 Indiana University Melvin and Bren Simon Cancer Center Support Grant INDIANA UNIVERSITY PATRICK J. LOEHRER
TL1 TR001107 Indiana Clinical and Translational Sciences Institute INDIANA UNIVERSITY Anantha Shekhar
UL1 TR001108 Indiana Clinical and Translational Sciences Institute INDIANA UNIVERSITY Anantha Shekhar
UL1 TR002529 Indiana Clinical and Translational Sciences Institute INDIANA UNIVERSITY Anantha Shekhar
Submission date Mar 09, 2018
Last update date Jan 14, 2020
Contact name Chang-Deng Hu
E-mail(s) hu1@purdue.edu
Organization name Purdue University
Department Department of Medicinal Chemistry and Molecular Pharmacology
Street address 201 S. University St, Hansen Life Sciences Building, Room 401A
City West Lafayette
State/province IN
ZIP/Postal code 47907
Country USA
 
Platforms (2)
GPL15520 Illumina MiSeq (Homo sapiens)
GPL16791 Illumina HiSeq 2500 (Homo sapiens)
Samples (12)
GSM3035189 IR- Dox- 1
GSM3035190 IR- Dox+ 1
GSM3035191 IR- Dox- 2
Relations
BioProject PRJNA437575
SRA SRP134236

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE111620_irradiation.counts.txt.gz 5.8 Mb (ftp)(http) TXT
GSE111620_non_irradiation.counts.txt.gz 5.7 Mb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap